Skip to main content

  • Use and performance of the evolut FX transcatheter aortic valve system

    • Posted: 10/01/2024
    • Author:

      Tanvir Bajwa, Guilherme F. Attizzani, Hemal Gada, Stanley J. Chetcuti, Mathew R. Williams, Mustafa Ahmed, George A. Petrossian, Matthew D. Saybolt, Suhail Q. Allaqaband, William M. Merhi, Robert C. Stoler, Hiram Bezerra, Paul Mahoney, Willis Wu, Robert Jumper, Larry Lambrecht and Gilbert H.L. Tang

    • CRMNews2024

    Abstract

    Background

    The next generation supra-annular, self-expanding Evolut FX transcatheter aortic valve (TAV) system was designed to improve catheter deliverability, provide stable and symmetric valve deployment, and assess commissural alignment during the procedure. The impact of these modifications has not been clinically evaluated.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details